Deepak Chadha - May 18, 2021 Form 4 Insider Report for Brickell Biotech, Inc. (FRTX)

Role: Chief Research & Dev. Officer
Signature: /s/ Christine G. Long, Attorney-in-Fact for Chadha Deepak (power of attorney previously filed)
Stock symbol: FRTX
Transactions as of: May 18, 2021
Transactions value $: $12,589
Form type: 4
Date filed: 5/19/2021, 05:01 PM
Next filing: Jun 14, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FRTX	Common Stock	Purchase	$2.21K	+2.7K	+4.29%	$0.82	65.7K	May 18, 2021	Direct
transaction	FRTX	Common Stock	Purchase	$10.4K	+12.5K	+19.04%	$0.83	78.2K	May 19, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the purchase of 12,500 shares in multiple transactions, ranging in price from $0.814 to $0.857 per share, resulting in a weighted average purchase price of $0.8302. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.